The Conafay Group (for Antimicrobials Working Group)
Biomedical representation
Based in DC
🤖
AI Overview
With $120K in lobbying spend across 12 quarterly filings, The Conafay Group (for Antimicrobials Working Group) is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2023 to 2025.
$120K
Total Spend
3
Years Active
1
Firms Hired
2
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $100K |
| 2024 | $20K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Health Issues, Science/Technology
- •Issues related to antimicrobials
- •FY24 Labor, Health and Human Services, Education Appropriations, issues related to antimicrobials.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.